{"id":"W2320592786","doi":"10.15420/aer.2014.3.3.194","title":"Stroke Prevention in Atrial Fibrillation – Outcomes and Future Directions","year":2014,"lang":"en","type":"article","venue":"Arrhythmia & Electrophysiology Review","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Medtronic (Canada)","funders":"Daiichi Sankyo Europe","keywords":"Edoxaban; Medicine; Rivaroxaban; Apixaban; Dabigatran; Atrial fibrillation; Stroke (engine); Direct thrombin inhibitor; Warfarin; TIMI; Internal medicine; Intensive care medicine; Cardiology; Myocardial infarction; Thrombolysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000257086,0.0001718717,0.0006670268,0.000125429,0.00007457358,0.000008355759,0.0000307108,0.00009923663,0.000100493],"category_scores_gemma":[0.0001779258,0.0001350899,0.0002732854,0.0002718648,0.00003485562,0.0001014054,0.00002868115,0.000144131,0.00004616678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004206413,"about_ca_system_score_gemma":0.0000303612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007286717,"about_ca_topic_score_gemma":0.00001229011,"domain_scores_codex":[0.9987441,0.0002134141,0.0004040614,0.000296751,0.0001136352,0.0002280219],"domain_scores_gemma":[0.9993963,0.0001232384,0.00015359,0.0002273231,0.00004340829,0.00005620357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002151329,0.000003962771,0.09120254,0.0008370173,0.0001980642,0.000004358247,0.00002706649,0.00001346937,0.002052301,0.006289059,0.0003622162,0.8987948],"study_design_scores_gemma":[0.001291356,0.0003763794,0.4098093,0.0002504697,0.0002593478,0.0000240213,0.000003406406,0.0001345875,0.0000157295,0.0008576645,0.5868312,0.0001465253],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8119954,0.1384108,0.0001964811,0.04450768,0.0008086605,0.002388565,0.000002905909,0.0001938725,0.001495602],"genre_scores_gemma":[0.5000677,0.4798774,0.001395611,0.001856865,0.01296151,0.00001842332,0.0001796567,0.00005229624,0.003590528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8986483,"threshold_uncertainty_score":0.5508808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02086866450948729,"score_gpt":0.319279567246149,"score_spread":0.2984109027366617,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}